ARYA Sciences Acquisition Corp. III (NASDAQ:ARYA) announced in an 8-K filing that its shareholders approved its combination with Nautilus Biotechnology at a special meeting earlier today.
The SPAC did not disclose redemption figures, but noted that 75.68% of shares participated in the vote, and the combination was approved nearly unanimously.
The transaction is now expected to close on June 9 with with the combined entity’s shares commencing trading on the Nasdaq under the symbols “NAUT” respectively on June 10.
The parties initially announced their $905 million deal on February 8. Nautilus is working to create a machine-learning technology platform for testing and mapping proteins and serve as an accelerant in biopharmaceutical research.
Although all measures on ARYA’s ballot passed by wide margins, some advisory governing document proposals received pushback. For a full list of proposals and vote tallies, click HERE.
ADVISORS
- Morgan Stanley is acting as lead financial advisor to Nautilus Biotechnology, with Cowen also acting as financial advisor to Nautilus Biotechnology.
- Wilson Sonsini Goodrich & Rosati, P.C., is acting as legal counsel to Nautilus Biotechnology.
- Jefferies LLC and Goldman Sachs & Co. LLC are acting as financial advisors to Arya III as well as private placement agents.
- Kirkland & Ellis LLP is acting as legal counsel to Arya III.
Vendome Acquisition Corporation I (NASDAQ:VNMEU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VNMEU”, Wednesday, July 2, 2025. The new SPAC plans to focus its search on target business in the consumer sector operating in North America, Southeast Asia, and Europe....
Origin Investment Corp. I (NASDAQ:ORIQU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIQU”, Wednesday, July 2, 2025. The new SPAC aims to mount a broad search for a target with a strong management and both revenue and earnings growth potential....
1RT Acquisition Corp. (NASDAQ:ONCHU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ONCHU”, Wednesday, July 2, 2025. The new SPAC plans to target company in the digital asset ecosystem involved in the creation, storage, exchange or management of such assets, whether...
D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...